Shannon Tarr

Breast Cancers With Brain Metastases are More Likely to be Estrogen Receptor Negative, Express the Basal Cytokeratin CK5/6, and Overexpress HER2 or EGFR

David G. Hicks, Sarah Short, Nichole Prescott et al. · The American Journal of Surgical Pathology · 2006 · 261 citations

Medicine, Oncology, Pathology +17

The Expression of Fascin, an Actin-Bundling Motility Protein, Correlates with Hormone Receptor–Negative Breast Cancer and a More Aggressive Clinical Course

Brian J. Yoder, Elisa Tso, Marek Skacel et al. · Clinical Cancer Research · 2005 · 184 citations · Full text

Medicine, Molecular Biology, Oncology +15

Novel Prognostic Immunohistochemical Biomarker Panel for Estrogen Receptor–Positive Breast Cancer

Brian Z. Ring, Robert S. Seitz, Rod Beck et al. · Journal of Clinical Oncology · 2006 · 181 citations

Medicine, Biostatistics, Oncology +17

Loss of Breast Cancer Metastasis Suppressor 1 Protein Expression Predicts Reduced Disease-Free Survival in Subsets of Breast Cancer Patients

David G. Hicks, Brian J. Yoder, Sarah Short et al. · Clinical Cancer Research · 2006 · 91 citations · Full text

Medicine, Genetics, Oncology +17

The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: A fluorescence in situ hybridization study

David G. Hicks, Brian J. Yoder, James Pettay et al. · Human Pathology · 2005 · 61 citations

Medicine, Genetics, Oncology +11